
Sign up to save your podcasts
Or
Full article: https://www.ajronline.org/doi/abs/10.2214/AJR.21.25924
Intracranial deposition of gadolinium after contrast-enhanced MRI is an emerging area of concern with much still to be learned. Kalen Riley, MD, MBA discusses a new article that proposes a dose-reduction strategy that takes advantage of relatively higher T1 relaxivity of one macrocyclic agent compared to another while still striving to maintain an adequate imaging examination.
4.5
4343 ratings
Full article: https://www.ajronline.org/doi/abs/10.2214/AJR.21.25924
Intracranial deposition of gadolinium after contrast-enhanced MRI is an emerging area of concern with much still to be learned. Kalen Riley, MD, MBA discusses a new article that proposes a dose-reduction strategy that takes advantage of relatively higher T1 relaxivity of one macrocyclic agent compared to another while still striving to maintain an adequate imaging examination.
16,477 Listeners
85 Listeners
27 Listeners
314 Listeners
26,416 Listeners
74 Listeners
27 Listeners
7,740 Listeners
6,633 Listeners
5,088 Listeners
200 Listeners
5,337 Listeners
15,336 Listeners
39 Listeners
421 Listeners